First-onset mental disorders after cancer diagnosis and cancer-specific mortality: a nationwide cohort study
|
|
- Lindsay Shields
- 5 years ago
- Views:
Transcription
1 Annals of Oncology 28: , 2017 doi: /annonc/mdx265 Published online 19 May 2017 ORIGINAL ARTICLE First-onset mental disorders after cancer diagnosis and cancer-specific mortality: a nationwide cohort study J. Zhu 1 *, F. Fang 1, A. Sjölander 1, K. Fall 1,2, H. O. Adami 1,3,4 & U. Valdimarsdottir 1,3,5 1 Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm; 2 Department of Clinical Epidemiology and Biostatistics, School of Medical Sciences, Orebro University, Orebro, Sweden; 3 Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, USA; 4 Clinical Effectiveness Research Group, Institute of Health and Society, University of Oslo, Oslo, Norway; 5 Center of Public Health Sciences, School of Health Sciences, Faculty of Medicine, University of Iceland, Reykjavık, Iceland *Correspondence to: Dr Jianwei Zhu, Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Box 281, Stockholm , Sweden. Tel: þ ; jianwei.zhu@ki.se Background: The diagnosis of cancer is strongly associated with the risk of mental disorders even in patients with no previous history of mental disorders. Accumulating data suggest that mental distress may accelerate tumor progression. We hypothesized therefore that mental disorders after a cancer diagnosis may increase the risk of cancer-specific mortality. Patients and methods: We conducted a nationwide cohort study including cancer patients diagnosed in Sweden during and followed them through Through the Swedish Patient Register, we obtained clinical diagnoses of all mental disorders and focused on mood-, anxiety-, and substance abuse disorders (ICD10: F10 F16, F18 F19, F32 F33, F40 F41, and F43 45) that are commonly diagnosed among patients with cancer. We further classified the studied mental disorders into first-onset or recurrent mental disorders. We used Cox regression to estimate multivariable hazard ratios (HRs) with 95% confidence intervals (CIs) as a measure of the association between mental disorders after cancer diagnosis and cancer-specific mortality, adjusting for age, sex, calendar period, educational level, cancer stage, and cancer type at diagnosis. Results: After cancer diagnosis, patients were diagnosed with mood-, anxiety-, and substance abuse disorders; of which 7236 were first-onset mental disorders. Patients with a first-onset mental disorder were at increased risk of cancer-specific mortality (HR: 1.82, 95% CI: ) while patients with a recurrent mental disorder had much lower risk elevation (HR: 1.14, 95% CI: ). The increased cancer-specific mortality by first-onset mental disorders was observed for almost all cancer sites/ groups and the association was stronger for localized cancers (HR: 2.00, 95% CI: ) than for advanced cancers (HR: 1.49, 95% CI: ). Conclusions: Patients with a first-onset common mood-, anxiety-, or substance abuse disorder after cancer diagnosis may be at increased risk of cancer-specific death. Key words: cancer, mental disorder, psychological stress, survival analysis, mortality Introduction Mental distress is common among cancer patients; around onethird of cancer patients have been reported to have mood disorders in the hospital setting [1]. Beyond the burden of living with cancer and its treatments, receiving a cancer diagnosis is also a severely stressful event. An excessive or prolonged psychological reaction to the diagnosis may itself be associated with other serious health consequences, including various psychiatric disorders [1, 2] and, in severe cases, even suicide and cardiovascular fatalities shortly after cancer diagnosis [3]. During the past decade, the evidence for the role of mental disorders in tumor progression and cancer-related mortality has been rapidly accumulating [4]. Studies have reported various mental disorders to be associated with higher rate of all-cause [5 7] or cancer-specific [8, 9] mortality. However, the findings of previous studies have often been inconsistent due to an array of VC The Author Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For Permissions, please journals.permissions@oup.com.
2 Annals of Oncology methodological difficulties, including small sample sizes and selfreported symptoms. Large studies on clinically confirmed mental disorders, specifically those after cancer diagnosis, and their potential influence on cancer-specific mortality are lacking. Furthermore, few past studies have addressed the potentially different roles of first-onset and recurrent mental disorders on cancer-specific survival. Recently, we demonstrated a rapid rise in first-onset mood-, anxiety-, and substance abuse disorders in patients undergoing diagnostic work-up and immediately after cancer [10]. In the present study, we aimed to examine the role of these common mental disorders diagnosed after the cancer on cancer-specific mortality. As an indication of a severe stress-related reaction after cancer, we hypothesized specifically that such first-onset mental disorders would be associated with increased cancer-specific death. Materials and methods Study design In Sweden, reporting cancers has been required legally since 1958 and the completeness of Cancer Register approaches 100% [11]. We conducted a cohort study on all adult patients (age 30) diagnosed with a primary cancer between 1 January 2004 and 31 December After exclusion of diagnoses confirmed at autopsy, our analytic cohort comprised cancer patients with information on age, sex, date of diagnosis, cancer stage, and the national registration number (NRN). The most common cancer types were prostate (N ¼ ), breast (N ¼ ), colorectal (N ¼ ), lung (N ¼ ), hematological (N ¼ ), and renal/ bladder (N ¼ ) cancers, as well as malignant melanoma (N ¼ ). Additionally, highly fatal cancers of the esophagus, liver, and pancreas were pooled together as severe cancers (N ¼ 6603). The individually unique NRN, allowed record linkages between the study cohort and the nationwide Patient, Causes of Death, Migration, Multi- Generation and Education Registers. Ascertainment of mental disorders In Sweden, all hospital discharge records have been collected in Patient Register since 1987 and >80% of outpatient visits for hospital-based specialist care since 2001 [12]. In this register, all diagnoses are coded from 1997 onward according to the 10th Swedish revision of International Classification of Diseases (ICD). We focused on common mood-, anxiety-, and substance abuse disorders, which have been shown to have a dramatic risk elevation after cancer [10], and are potentially related to severe psychological stress [13]. These included substance abuse (ICD10: F10 F16/F18 F19), depression (ICD10: F32 F33), stress reaction/adjustment disorder (ICD10: F43), anxiety (ICD10: F40 F41), and somatoform/conversion disorder (ICD10: F44 F45). Other mental disorders (ICD10: F00 F99 excluding the studied diagnoses above) were classified as the secondary exposure, leaving cancer patients without any mental disorder after cancer as the unexposed group. The first diagnosis of mental disorders after the date of cancer diagnosis, either through inpatient or outpatient care was used as a time-varying variable, and patients were classified as exposed from the diagnosis date of mental disorder. Ascertainment of mortality Cancer patients were followed from the date of cancer diagnosis until death or 31 December 2010, whichever occurred first. From Causes of Death Register, we identified date and underlying cause of death. If the cancer diagnosis and the underlying cause of death indicated the same site/group of cancer, the study participant was defined as having a cancer-specific death (supplementary Table S1, available at Annals of Oncology online). Statistical analysis We used Cox regression to assess the association of mental disorders after cancer with cancer-specific mortality, estimating hazard ratios (HRs) with 95% confidence intervals (CIs). We first estimated the overall associations between the studied mental disorders and cancer-specific mortality, and then by mental disorders diagnosed within or beyond 90 days after cancer. We then carried out separate analyses for patients with and without a history of mental disorders before cancer. Patients diagnosed with mental disorders after cancer and without a previous history of any mental disorder before cancer (from 1 January 1987) were classified as having a first-onset mental disorder, while others were classified as having a recurrent mental disorder. The analysis was first conducted for all cancer types together and then separately for the most common sites/groups. To separately assess the role of specific mental disorders, we further carried out the analysis by individual diagnosis. To assess potential effect modifications, we further stratified the analysis by age, sex, calendar period, educational level, number of close relatives (including partner, children, and siblings; 2, 3 5, and 6), and cancer stage at diagnosis. The number of close relatives was ascertained through linking to Multi- Generation Register, which contains information on familial links for all Swedish residents born since 1932 onward. In all statistical models, we used age at follow-up as the underlying timescale and adjusted for age, sex, calendar period ( / ), educational level (>9/9 years), and cancer stage at diagnosis. In the analysis of all cancers, we further adjusted for cancer site/group (supplementary Table S1, available at Annals of Oncology online). In the analysis of hematological malignancies, subtype (Hodgkin/non-Hodgkin lymphoma, myeloma, and leukemia) was further adjusted for. Information on cancer stage was ascertained by the TNM or FIGO records, including localized (T-localized/N0/M0, FIGO-0/I), local spread (T-advanced/N0/M0, FIGO-II), regional spread (Nþ/M0, FIGO-III), and advanced (Mþ, FIGO-IV) cancers [14]. Cancer patients with mental disorders adjacent to their diagnosis may receive different treatment regimens, leading to potentially different mortality. To test this hypothesis, we compared the percentage of and waiting-time for surgical treatments among patients with prostate, lung, or colorectal cancers (where surgical treatment is commonly used as the primary treatment), according to their exposure to the studied mental disorders. We also repeated the main analyses after further adjustment for surgery among patients with these cancers. All the statistical analyses were carried out in SAS9.4 and Stata13.1. The study was approved by the Regional Ethics Review Board in Stockholm, Sweden. Results Original article After cancer diagnosis, patients experienced the studied mental disorder including 7236 with first-onset, and patients experienced other mental disorders including 6661 with first-onset. A higher proportion of patients with the studied mental disorders was female and diagnosed as cancer below age 65 years (Table 1). Patients with the studied mental disorders after cancer had a 53% increased cancer-specific mortality compared with patients without any mental disorders. The association was considerably stronger for first-onset than recurrent mental disorders (Table 2). No statistically significant association was noted between recurrent mental disorders and cancer-specific mortality in the Volume 28 Issue doi: /annonc/mdx
3 Original article Table 1. Baseline characteristics of study participants in a cohort study of cancer patients in Sweden, diagnosed from 2004 to 2009 Without mental disorders after cancer Studied mental disorders after cancer diagnosis a N Sex (%) Male Female Age at follow-up (%) 65, years > Calendar period at diagnosis (%) Educational level >9 years years Missing Previous mental disorders (%) No Yes Cancer stage c (%) Localized Local spread Regional spread Advanced Unknown Missing Close relatives d Unknown Other mental disorders after cancer diagnosis b a Studied mental disorders included depression (ICD10: F32 F33), anxiety (ICD: F40 F41), stress reaction and adjustment disorder (ICD10: F43), mental and behavioral disorders due to psychoactive substance use (ICD10: F10 F16, F18 F19), and somatoform/conversion disorder (ICD10: F44 F45). b Other mental disorders included any mental disorders (ICD10: F00 F99), except for the studied mental disorders. c Cancer stage at diagnosis was defined according to TNM or FIGO records and was not available for hematological and central nervous system malignancies. Patients with hematological and central nervous system malignancies were classified in the group entitled Missing. d Close relatives include partner, children, and siblings who have not died at cancer diagnosis. People with whom cancer patients had biological children are classified as partner. analyses of specific cancer sites/groups while first-onset mental disorders were associated with a higher risk of cancer-specific mortality among all common cancer types (Figure 1). The increased cancer-specific mortality was observed for both mental disorders experienced within and beyond 90 days after cancer (Table 2). Patients diagnosed with other mental disorders also showed increased cancer-specific mortality, regardless of whether the mental disorders were first-onset or recurrent (supplementary Table S2 and Figure S1, available at Annals of Oncology online). In the stratified analysis, the excess cancer-specific mortality by first-onset mood-, anxiety-, and substance abuse disorders did not appear to differ largely between men and women; neither by age, calendar period, educational level, or number of close relatives (Table 3). However, the association was stronger among patients with a diagnosis of lower stage cancers. Almost all subtypes of the first-onset mental disorders (depression, anxiety, stress reaction/adjustment disorder, and substance abuse) were associated with increased cancer-specific mortality (Table 4). Compared with unexposed patients, patients with a first-onset mood-, anxiety-, or substance abuse disorder had a similar (prostate cancer, P > 0.05) or a slightly higher (lung or colorectal cancer, P < 0.05) prevalence of surgery (supplementary Table S3, available at Annals of Oncology online). Patients with these mental disorders had also similar waiting-time for surgery compared with unexposed patients (P > 0.05). Adding surgery to the original models did not alter the results. Discussion Annals of Oncology The findings from this nationwide cohort study of more than individuals suggest that patients diagnosed for the first time with common mood-, anxiety-, and substance abuse disorders after their cancer experience increased risk of cancerspecific death. The increased cancer-specific mortality was noted across all tested cancer sites and was particularly strong in the case of early stage cancers. Our findings support the hypothesis that mental disorders may be strongly associated with survival prospects of patients diagnosed with cancer a finding that calls for further exploration of mechanism as well as enhanced clinical monitoring and treatment of these symptoms among cancer patients. To the best of our knowledge, the present study is the first large scale endeavor to evaluate the influence of clinically confirmed first-onset mental disorders after cancer on cancer-specific mortality. Previous research lends support to an association between psychological disorders and cancer mortality [4]. In line with earlier findings [8, 9, 15], our data suggest that cancer patients face shorter cancer-specific survival specifically when diagnosed with first-onset mood-, anxiety-, and substance abuse disorders after cancer. It is possible that first-onset mental disorders represent a severe stress reaction specifically due to the diagnosis and living with cancer whilst a recurrent onset may demark a general lability for mental disorders, which might play a smaller role in cancer progression. Similar findings were indeed observed in a recent Danish study, showing that only bereavement with its associated risk of mental disorders occurring after but not before cancer diagnosis was associated with cancer mortality [16]. Nevertheless, why patients with recurrent mental disorders do not experience similar elevation in cancer-specific mortality is enigmatic and calls for further studies. Several different pathways may explain the associations between the studied mental disorders and cancer-specific mortality Zhu et al. Volume 28 Issue
4 Annals of Oncology Table 2. Association of studied mental disorders and cancer-specific mortality, shown by time from cancer diagnosis, stratified by previous mental disorders Studied mental disorders a Studied mental disorders within 90 days after cancer Studied mental disorders over 90 days after cancer N HR (95% CI) b N HR (95% CI) N HR (95% CI) Overall ( ) ( ) ( ) Previous mental disorders c No ( ) ( ) ( ) Yes ( ) ( ) ( ) a Studied mental disorders included depression (ICD10: F32 F33), anxiety (ICD: F40 F41), stress reaction and adjustment disorder (ICD10: F43), mental and behavioral disorders due to psychoactive substance use (ICD10: F10 F16, F18 F19), and somatoform/conversion disorder (ICD10: F44 F45). b HR, hazard ratio; CI, confident interval; models adjusted for age at cancer diagnosis, sex, calendar period of cancer diagnosis, cancer type, cancer stage at diagnosis, educational, and history of mental disorder before cancer diagnosis; patients without any mental disorders after cancer diagnosis were used as the reference group. c A previous history of any mental disorder (after 1 January 1987) (ICD10: F00 F99). Original article Prostate cancer 1.84 ( ) 2.42 ( ) 1.23 ( ) Breast cancer 1.32 ( ) 1.54 ( ) 1.05 ( ) Lung cancer 1.42 ( ) 1.68 ( ) 1.14 ( ) Colorectal cancer 1.35 ( ) 1.54 ( ) 1.14 ( ) Melanoma 1.71 ( ) 2.38 ( ) 0.62 ( ) Hematological malignance 1.63 ( ) 1.84 ( ) 1.21 ( ) Renal/bladder cancer 1.86 ( ) 2.43 ( ) 1.38 ( ) Severe cancers 1.19 ( ) 1.30 ( ) 1.34 ( ) Overall First-onset mental disorders Recurrent mental disorders Figure 1. Hazard ratios of cancer-specific mortality among patients with studied mental disorders after cancer diagnosis when compared with patients without any mental disorders after cancer diagnosis, further stratified with respect to previous mental disorders (ICD10: F00 F99). First, a mental disorder occurring in conjunction with cancer may influence treatment decisions. Yet, our secondary analysis did not show less prevalence of or longer waiting-time for curative treatment (i.e. surgery) among patients with prostate, lung, and colorectal cancers that had first-onset mental disorders after cancer. Second, although adjuvant cancer treatments, e.g. chemotherapy or radiation, could increase the risk of mood disorders, they might also be associated with extended survival. Not taking into account adjuvant therapy could therefore result in an attenuation of our point estimates. Third, psychopharmacological treatment of mental disorders could potentially mediate the association between mental disorders and cancer survival. Data are still limited on the association of psychotic medication and cancer-specific mortality [17, 18]. Thus, the role of psychopharmacological treatment as a mechanism between first-onset mental disorders and cancer progression cannot be excluded and warrants further study. Finally, downstream physiologic consequences of the patients mental health may independently affect tumor progression and survival [19]. Mental disorders, e.g. anxiety and depression, can cause activation in the hypothalamic pituitary adrenal axis and autonomic nervous system with corresponding deregulation of circadian cortisol rhythm and release of catecholamine [19]. In an animal model where circadian cortisol rhythm was blunted, implanted osteosarcomas and pancreatic adenocarcinomas grew significantly faster than in sham-operated animals [20]. Furthermore, the loss of normal circadian variation in cortisol was associated with earlier mortality among lung [21] and breast cancer [22] patients. The major strength of our study is the large-scale populationbased cohort design, the complete follow-up and the independently and prospectively collected data on cancer, mental disorders, and cause of death. A few limitations should nevertheless be noted. First, mental disorders are a group of diseases associated with multiple etiologies ranging from environmental to genetic factors. Our main exposure, first-onset mood-, anxiety-, and substance abuse disorders after cancer, may potentially be a proxy for stress reaction to receiving cancer diagnosis or living with cancer, but could also be related to other causes. Second, we used clinically confirmed mental disorders as exposure, which likely Volume 28 Issue doi: /annonc/mdx
5 Original article Table 3. Association of new-onset of studied mental disorders a after cancer and cancer-specific mortality, stratified by background characteristics N (%) HR (95% CI) b Sex Male 3082 (42.59) 1.93 ( ) Female 4154 (57.41) 1.71 ( ) Age at follow-up, years (53.98) 1.73 ( ) (24.67) 1.99 ( ) > (21.35) 1.77 ( ) Calendar period at diagnosis (59.56) 1.78 ( ) (40.44) 1.89 ( ) Educational level >9 years 4705 (65.02) 1.75 ( ) 9 years 2515 (34.76) 1.88 ( ) Cancer stage c Localized 3020 (41.74) 2.00 ( ) Local spread 826 (11.42) 2.04 ( ) Regional spread 1041 (14.39) 1.85 ( ) Advanced 471 (6.51) 1.49 ( ) Unknown 1139 (15.74) 1.65 ( ) Close relatives d (22.18) 1.76 ( ) (46.64) 1.84 ( ) (25.77) 1.84 ( ) Unknown 391 (5.40) 1.71 ( ) a Studied mental disorders included depression (ICD10: F32 F33), anxiety (ICD: F40 F41), stress reaction and adjustment disorder (ICD10: F43), mental and behavioral disorders due to psychoactive substance use (ICD10: F10 F16, F18 F19), and somatoform/conversion disorder (ICD10: F44 F45). b HR, hazard ratio; CI, confident interval; models adjusted for age at cancer diagnosis, sex, calendar period of cancer diagnosis, cancer type, cancer stage at diagnosis, educational, and history of mental disorder before cancer diagnosis; patients without any mental disorders after cancer diagnosis were used as the reference group. c Cancer stage at diagnosis was defined according to TNM or FIGO records and was not available for hematological and central nervous system malignancies. Patients with hematological and central nervous system malignancies were classified in the group entitled Missing. d Close relatives include partner, children, and siblings who have not died at cancer diagnosis. People with whom cancer patients had biological children are classified as partner. indicate the most severe cases of mental distress. Patients with milder forms of mental distress that did not receive a clinical diagnosis were classified as unexposed, probably leading to an underestimate of the real associations. Third, the burden of mental disorders among cancers of very poor prognosis might have been underestimated. Fourth, we did not have complete information on cancer treatments. However, our secondary analyses with further adjustment for surgical treatment did not alter the results of prostate, lung and colorectal cancers. Further, it is possible that small number of patients died from other comorbidities Table 4. Association of specific diagnosis of new-onset studied mental disorders a after cancer and cancer-specific mortality, stratified by previous mental disorder b N (%) HR (95% CI) c Stress reaction 832 (11.50) 1.78 ( ) Depression 3109 (42.97) 1.76 ( ) Anxiety 2061 (28.48) 2.11 ( ) Substance abuse 926 (12.80) 1.50 ( ) Somatoform/conversion disorder 308 (4.26) 1.20 ( ) a Studied mental disorders included depression (ICD10: F32 F33), anxiety (ICD: F40 F41), stress reaction and adjustment disorder (ICD10: F43), mental and behavioral disorders due to psychoactive substance use (ICD10: F10 F16, F18 F19), and somatoform/conversion disorder (ICD10: F44 F45). b Any mental disorders (ICD10: F00 F99). c HR, hazard ratio; CI, confident interval; models adjusted for age at cancer diagnosis, sex, calendar period of cancer diagnosis, cancer type, cancer stage at diagnosis, educational, and history of mental disorder before cancer diagnosis; patients without any mental disorders after cancer diagnosis were used as the reference group. were misclassified as from cancer, or vice versa. However, it is unlikely that this misclassification was related to mental disorders and this source of error would only dilute the reported associations. Finally, in this study cancer patients were only followed for an average of 2.9 years. Thus, future studies with longer follow-up times are needed to explore the association between mental disorders and longer-term survival. In conclusion, our findings suggest that patients experiencing a first-onset mood-, anxiety-, or substance abuse disorder after cancer may face increased risk of cancer-specific death. In an effort to optimize quality of life and survival prospects of newly diagnosed cancer patients, our findings motivate further study of underlying mechanisms as well as closer monitoring, and treatment, of severe mental disorders among these patients. Funding This study was supported by the Swedish Cancer Society (CAN 2014/417), the Swedish Research Council for Health, Working Life and Welfare ( ), the China Scholarship Council ( ), the Swedish Society for Medical Research (SSMF, no grant number is applicable), Karolinska Institutet Distinguished Professor Award (2368/ to HOA), and the Karolinska Institutet Senior Researcher Grant and the Strategic Research Area in Epidemiology (to FF, no grant number is applicable). Disclosure The authors have declared no conflicts of interest. Annals of Oncology 1968 Zhu et al. Volume 28 Issue
6 Annals of Oncology References 1. Mitchell AJ, Chan M, Bhatti H et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliativecare settings: a meta-analysis of 94 interview-based studies. Lancet Oncol 2011; 12: Vin-Raviv N, Hillyer GC, Hershman DL et al. Racial disparities in posttraumatic stress after diagnosis of localized breast cancer: the BQUAL study. J Natl Cancer Inst 2013; 105: Fang F, Fall K, Mittleman MA et al. Suicide and cardiovascular death after a cancer diagnosis. N Engl J Med 2012; 366: Chida Y, Hamer M, Wardle J, Steptoe A. Do stress-related psychosocial factors contribute to cancer incidence and survival? Nat Clin Prac Oncol 2008; 5: Prasad SM, Eggener SE, Lipsitz SR et al. Effect of depression on diagnosis, treatment, and mortality of men with clinically localized prostate cancer. J Clin Oncol 2014; 32: Watson M, Haviland JS, Greer S et al. Influence of psychological response on survival in breast cancer: a population-based cohort study. Lancet 1999; 354: Wikman A, Ljung R, Johar A et al. Psychiatric morbidity and survival after surgery for esophageal cancer: a population-based cohort study. J Clin Oncol 2015; 33: Batty GD, Russ TC, Stamatakis E, Kivimaki M. Psychological distress in relation to site specific cancer mortality: pooling of unpublished data from 16 prospective cohort studies. Br Med J 2017; 356: j Epplein M, Zheng Y, Zheng W et al. Quality of life after breast cancer diagnosis and survival. J Clin Oncol 2011; 29: Lu D, Andersson TM, Fall K et al. Clinical diagnosis of mental disorders immediately before and after cancer diagnosis: a Nationwide Matched Cohort Study in Sweden. JAMA Oncol 2016; 2: Original article 11. Barlow L, Westergren K, Holmberg L, Talback M. The completeness of the Swedish Cancer Register: a sample survey for year Acta Oncol 2009; 48: Ludvigsson JF, Andersson E, Ekbom A et al. External review and validation of the Swedish national inpatient register. BMC Public Health 2011; 11: Klengel T, Binder EB. Epigenetics of Stress-related psychiatric disorders and gene x environment interactions. Neuron 2015; 86: Berrino B, Möller S. In Condensed TNM for Coding the Extent of Disease. Recommendations issued by ENCR: The European Network of Cancer Registries (ENCR), Pirl WF, Greer JA, Traeger L et al. Depression and survival in metastatic non-small-cell lung cancer: effects of early palliative care. J Clin Oncol 2012; 30: Levav I, Kohn R, Iscovich J et al. Cancer incidence and survival following bereavement. Am J Public Health 2000; 90: Ranjan A, Gupta P, Srivastava SK. Penfluridol: an antipsychotic agent suppresses metastatic tumor growth in triple-negative breast cancer by inhibiting integrin signaling axis. Cancer Res 2016; 76: Chubak J, Buist DS, Boudreau DM et al. Breast cancer recurrence risk in relation to antidepressant use after diagnosis. Breast Cancer Res Treat 2008; 112: Reiche EM, Nunes SO, Morimoto HK. Stress, depression, the immune system, and cancer. Lancet Oncol 2004; 5: Filipski E, King VM, Li X et al. Host circadian clock as a control point in tumor progression. J Natl Cancer Inst 2002; 94: Sephton SE, Lush E, Dedert EA et al. Diurnal cortisol rhythm as a predictor of lung cancer survival. Brain Behav Immun 2013; 30 Suppl: S163 S Sephton SE, Sapolsky RM, Kraemer HC, Spiegel D. Diurnal cortisol rhythm as a predictor of breast cancer survival. J Natl Cancer Inst 2000; 92: Volume 28 Issue doi: /annonc/mdx
How research based on Swedish registries improve health: an international perspective? Hans-Olov Adami
How research based on Swedish registries improve health: an international perspective? Hans-Olov Adami Department of Epidemiology Harvard School of Public Health Department of Medical Epidemiology and
More informationSuicide and Cardiovascular Death after a Cancer Diagnosis
T h e n e w e ngl a nd j o u r na l o f m e dic i n e original article Suicide and Cardiovascular Death after a Cancer Diagnosis Fang Fang, M.D., Ph.D., Katja Fall, M.D., Ph.D., Murray A. Mittleman, M.D.,
More informationChallenges in design and analysis of large register-based epidemiological studies
FMS/DSBS autumn meeting 2014 Challenges in design and analysis of large register-based epidemiological studies Caroline Weibull & Anna Johansson Department of Medical Epidemiology and Biostatistics (MEB)
More informationWeekday of esophageal cancer surgery and its relation to prognosis. Lagergren, Jesper; Mattsson Fredrik; Lagergren, Pernilla.
This is an author produced version of a paper accepted by Annals of Surgery. This paper has been peer-reviewed but does not include the final publisher proof-corrections or journal pagination. Weekday
More informationSupplementary Methods
Supplementary Materials for Suicidal Behavior During Lithium and Valproate Medication: A Withinindividual Eight Year Prospective Study of 50,000 Patients With Bipolar Disorder Supplementary Methods We
More informationCancer incidence in type 1 diabetes: A 5-country study of 9,000 cancers in type 1 diabetic individuals. Electronic Supplementary Material
Cancer incidence in type 1 diabetes: A -country study of 9, cancers in type 1 diabetic individuals Electronic Supplementary Material http://bendixcarstensen.com/dmca/t1d/t1d-ca-suppl.pdf February 216 Compiled
More informationTrends in Cancer Survival in NSW 1980 to 1996
Trends in Cancer Survival in NSW 19 to 1996 Xue Q Yu Dianne O Connell Bruce Armstrong Robert Gibberd Cancer Epidemiology Research Unit Cancer Research and Registers Division The Cancer Council NSW August
More informationMethodological choices affect cancer incidence rates: a cohort study
Brooke et al. Population Health Metrics (2017) 15:2 DOI 10.1186/s12963-017-0120-x RESEARCH Open Access Methodological choices affect cancer incidence rates: a cohort study Hannah L. Brooke *, Mats Talbäck,
More informationAnn Rheum Dis 2017;76: doi: /annrheumdis Lin, Wan-Ting 2018/05/161
Ann Rheum Dis 2017;76:1642 1647. doi:10.1136/annrheumdis-2016-211066 Lin, Wan-Ting 2018/05/161 Introduction We and others have previously demonstrated an increased risk of acute coronary syndrome (ACS)
More informationStress related disorders and risk of cardiovascular disease: population based, sibling controlled cohort study
For numbered affiliations see end of the article. Correspondence to: H Song huan@hi.is or huan.song@ki.se (ORCID 0000-0003-3845-8079) Additional material is published online only. To view please visit
More informationChildhood onset inflammatory bowel disease and risk of cancer: a Swedish nationwide cohort study
Childhood onset inflammatory bowel disease and risk of cancer: a Swedish nationwide cohort study 6- O Olén,,, J Askling, MC Sachs, P Frumento, M Neovius, KE Smedby, A Ekbom, P Malmborg,,5 JF Ludvigsson
More informationLow-dose capecitabine (Xeloda) for treatment for gastrointestinal cancer
Med Oncol (2014) 31:870 DOI 10.1007/s12032-014-0870-2 ORIGINAL PAPER Low-dose capecitabine (Xeloda) for treatment for gastrointestinal cancer Jasmine Miger Annika Holmqvist Xiao-Feng Sun Maria Albertsson
More informationCancer in Utah: An Overview of Cancer Incidence and Mortality from
Cancer in Utah: An Overview of Cancer Incidence and Mortality from 1973-2010 A publication of the Utah Cancer Registry January 2014 Prepared by: C. Janna Harrell, MS Senior Research Analyst Kimberly A.
More informationNational Cancer Registration and Analysis Service Short Report: Chemotherapy, Radiotherapy and Surgical Tumour Resections in England: (V2)
National Cancer Registration and Analysis Service Short Report: Chemotherapy, Radiotherapy and Surgical Tumour Resections in England: 13-14 (V2) Produced as part of the Cancer Research UK - Public Health
More information2018 Texas Cancer Registry Annual Report
2018 Texas Cancer Registry Annual Report As Required by Texas Health and Safety Code Section 82.007 November 2018 Table of Contents Executive Summary... 1 1. Introduction... 2 2. Background... 3 Cancer
More informationCancer prevalence. Chapter 7
Chapter 7 Cancer prevalence Prevalence measures the number of people diagnosed with cancer who are still alive. This chapter presents current and historical statistics on cancer prevalence in Ontario.
More informationCHAPTER 10 CANCER REPORT. Jeremy Chapman. and. Angela Webster
CHAPTER 10 CANCER REPORT Jeremy Chapman and Angela Webster CANCER REPORT ANZDATA Registry 2004 Report This report summarises the cancer (excluding nonmelanocytic skin cancer) experience of patients treated
More informationChildhood Cancer Survivor Study Analysis Concept Proposal
Title: Multiple Subsequent Neoplasms Working Group and Investigators: Childhood Cancer Survivor Study Analysis Concept Proposal This proposed publication will be within the Second Malignancy Working Group
More informationThe validity of the mortality to incidence ratio as a proxy for site-specific cancer survival
European Journal of Public Health, Vol. 21, No. 5, 573 577 ß The Author 2010. Published by Oxford University Press on behalf of the European Public Health Association. All rights reserved. doi:10.1093/eurpub/ckq120
More informationHu J, Gonsahn MD, Nerenz DR. Socioeconomic status and readmissions: evidence from an urban teaching hospital. Health Aff (Millwood). 2014;33(5).
Appendix Definitions of Index Admission and Readmission Definitions of index admission and readmission follow CMS hospital-wide all-cause unplanned readmission (HWR) measure as far as data are available.
More informationFinland and Sweden and UK GP-HOSP datasets
Web appendix: Supplementary material Table 1 Specific diagnosis codes used to identify bladder cancer cases in each dataset Finland and Sweden and UK GP-HOSP datasets Netherlands hospital and cancer registry
More informationEdinburgh Research Explorer
Edinburgh Research Explorer Psychological distress as a risk factor for dementia death Citation for published version: Russ, TC, Hamer, M, Stamatakis, E, Starr, J & Batty, GD 2011, 'Psychological distress
More informationSupplementary Online Content
Supplementary Online Content Henson KE, Brock R, Charnock J, Wickramasinghe B, Will O, Pitman A. Risk of suicide after cancer diagnosis in England. JAMA Psychiatry. Published online November 21, 2018.
More informationTheresa Keegan, Ph.D., M.S. Associate Professor Department of Internal Medicine Division of Hematology and Oncology
Impact of treatment and insurance on socioeconomic disparities in survival after adolescent and young adult Hodgkin lymphoma: A population- based study Theresa Keegan, Ph.D., M.S. Associate Professor Department
More informationIJC International Journal of Cancer
IJC International Journal of Cancer Cancer risks in twins and singletons from twin and non-twin families Lingjing Chen 1, Sven Cnattingius 1, Anastasia Nyman Iliadou 2 and Anna Sara Oberg 2,3 1 Department
More informationParental antibiotics and childhood asthma : a population-based study. Örtqvist, A.K.; Lundholma, C.; Fang, F.; Fall, T.; Almqvist, C.
This is an author produced version of a paper accepted by Journal of Allergy and Clinical Immunology. This paper has been peer-reviewed but does not include the final publisher proof-corrections or journal
More informationExtract from Cancer survival in Europe by country and age: results of EUROCARE-5 a population-based study
EUROCARE-5 on-line database Data and methods Extract from Cancer survival in Europe 1999 2007 by country and age: results of EUROCARE-5 a population-based study De Angelis R, Sant M, Coleman MP, Francisci
More information1. Study Title. Exercise and Late Mortality in 5-Year Survivors of Childhood Cancer: a Report from the Childhood Cancer Survivor Study.
CCSS Analysis Concept Proposal Exercise, Mortality, & Childhood Cancer 1 1. Study Title. Exercise and Late Mortality in 5-Year Survivors of Childhood Cancer: a Report from the Childhood Cancer Survivor
More informationOutcomes Report: Accountability Measures and Quality Improvements
Outcomes Report: Accountability Measures and Quality Improvements The FH Memorial Medical Center s Cancer Committee ensures that patients with cancer are treated according to the nationally accepted measures.
More informationHomogeneous Prostate Cancer Mortality in the Nordic Countries Over Four Decades
EUROPEAN UROLOGY 58 (2010) 427 432 available at www.sciencedirect.com journal homepage: www.europeanurology.com Prostate Cancer Homogeneous Prostate Cancer Mortality in the Nordic Countries Over Four Decades
More informationCancer in the Northern Territory :
Cancer in the Northern Territory 1991 21: Incidence, mortality and survival Xiaohua Zhang John Condon Karen Dempsey Lindy Garling Acknowledgements The authors are grateful to the many people, who have
More informationAnnual report on status of cancer in China, 2010
Original Article Annual report on status of cancer in China, 2010 Wanqing Chen, Rongshou Zheng, Siwei Zhang, Ping Zhao, Hongmei Zeng, Xiaonong Zou, Jie He National Office for Cancer Prevention and Control,
More informationTiming of Familial Breast Cancer in Sisters
ARTICLE Timing of Familial Breast Cancer in Sisters Paola Rebora, Kamila Czene, Marie Reilly Background Methods Results Conclusions Women who have had a first-degree relative diagnosed with breast cancer
More informationAnnual report on status of cancer in China, 2011
Original Article Annual report on status of cancer in China, 2011 Wanqing Chen, Rongshou Zheng, Hongmei Zeng, Siwei Zhang, Jie He National Office for Cancer Prevention and Control, National Cancer Center,
More informationPhase-specific Costs of Cancer Care in Ontario
Phase-specific Costs of Cancer Care in Ontario Canadian Association of Health Services and Policy Research Conference Session: D5 Cancer Care Wednesday May 29 2013 Claire de Oliveira, M.A. PhD Background
More informationUpper Gastrointestinal Research (UGIR) Jesper Lagergren, professor of surgery Karolinska Institutet and King s Health Partners London
Upper Gastrointestinal Research (UGIR) Jesper Lagergren, professor of surgery Karolinska Institutet and King s Health Partners London UGIR SIMSAM funding in 2008 Creation of UGIR (Upper Gastro-Intestinal
More informationThe poor cancer patient - social inequality in outcomes after cancer
The poor cancer patient - social inequality in outcomes after cancer Susanne Dalton Senior Researcher, MD, PhD Survivorship Danish Cancer Society Research Center This talk 2 Social position and cancer
More informationLung Cancer in Women: A Different Disease? James J. Stark, MD, FACP
Lung Cancer in Women: A Different Disease? James J. Stark, MD, FACP Medical Director, Cancer Program and Director of Palliative Care Maryview Medical Center Professor of Medicine Eastern Virginia Medical
More informationCANCER LEADERSHIP COUNCIL
CANCER LEADERSHIP COUNCIL A PATIENT-CENTERED FORUM OF NATIONAL ADVOCACY ORGANIZATIONS ADDRESSING PUBLIC POLICY ISSUES IN CANCER November 17, 2015 Andy Slavitt Acting Administrator Centers for Medicare
More informationTrends in cancer incidence in South East England Henrik Møller and all staff at the Thames Cancer Registry, King s College London
Trends in cancer incidence in South East England 1960-2009 Henrik Møller and all staff at the Thames Cancer Registry, King s College London 1 2 3 Analysts Vicki Coupland Ruth Jack Margreet Lüchtenborg
More informationEpidemiology in Texas 2006 Annual Report. Cancer
Epidemiology in Texas 2006 Annual Report Cancer Epidemiology in Texas 2006 Annual Report Page 94 Cancer Incidence and Mortality in Texas, 2000-2004 The Texas Department of State Health Services Texas Cancer
More informationIdentifying and counting people living with treatable but not curable cancer
Identifying and counting people living with treatable but not curable cancer Rachel White Joanna Pethick, Archie Macnair, Gregory Fallica, Jennifer Than and Jane Maher September 2018 Who are the people
More informationSex differences in mortality among patients admitted with affective disorders in North Norway -
Sex differences in mortality among patients admitted with affective disorders in North Norway - a 33-year prospective register study Anne Høye a,b, Ragnar Nesvåg c,d, Ted Reichborn-Kjennerud c, Bjarne
More informationSTANCE Program: Studying social services, treatment and other interventions for Alcohol and Narcotics and resulting health outcomes Age, Gender,
STANCE Program: Studying social services, treatment and other interventions for Alcohol and Narcotics and resulting health outcomes Age, Gender, education and country of birth differences in health outcomes
More informationAnnual European Congress of Rheumatology (EULAR) Madrid, Spain, June 2017
Annual European Congress of Rheumatology (EULAR) 2017 Madrid, Spain, 14-17 June 2017 NEW DATA SUGGEST NO INCREASED CANCER RISK FOR RA PATIENTS PRESCRIBED BIOLOGICAL DMARDS Reassuring findings may positively
More informationBirth Rate among Patients with Epilepsy: A Nationwide Population-based Cohort Study in Finland
American Journal of Epidemiology Copyright 2004 by the Johns Hopkins Bloomberg School of Public Health All rights reserved Vol. 159, No. 11 Printed in U.S.A. DOI: 10.1093/aje/kwh140 Birth Rate among Patients
More informationInfluence of psychological response on breast cancer survival: 10-year follow-up of a population-based cohort
European Journal of Cancer 41 (2005) 1710 1714 European Journal of Cancer www.ejconline.com Influence of psychological response on breast cancer survival: 10-year follow-up of a population-based cohort
More informationCancer in Rural Illinois, Incidence, Mortality, Staging, and Access to Care. April 2014
Cancer in Rural Illinois, 1990-2010 Incidence, Mortality, Staging, and Access to Care April 2014 Prepared by Whitney E. Zahnd, MS Research Development Coordinator Center for Clinical Research Southern
More informationTHE BURDEN OF CANCER IN NEBRASKA: RECENT INCIDENCE AND MORTALITY DATA
THE BURDEN OF CANCER IN NEBRASKA: RECENT INCIDENCE AND MORTALITY DATA Presented by: Bryan Rettig, MS Nebraska Dept. of Health & Human Services Division of Public Health May 31, 2017 Nebraska Cancer Registry
More informationTitle: Incidence of pelvic inflammatory disease in a large cohort of women tested for Chlamydia trachomatis: a historical follow-up study
Author's response to reviews Title: Incidence of pelvic inflammatory disease in a large cohort of women tested for Chlamydia trachomatis: a historical follow-up study Authors: Inger J Bakken (inger.bakken@sintef.no)
More informationFatal primary malignancy of brain. Glioblasatoma, histologically
TABLE 10.2 TBI and Brain Tumors Reference Study Design Population Type of TBI Health s or Annegers et al., 1979 Burch et al., 1987 Carpenter et al., 1987 Hochberg et al., 1984 Double cohort All TBI in
More informationEffects of Prostate-Specific Antigen Testing on Familial Prostate Cancer Risk Estimates
DOI: 10.1093/jnci/djq265 Advance Access publication on August 19, 2010. The Author 2010. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org.
More informationLong-term survival of cancer patients in Germany achieved by the beginning of the third millenium
Original article Annals of Oncology 16: 981 986, 2005 doi:10.1093/annonc/mdi186 Published online 22 April 2005 Long-term survival of cancer patients in Germany achieved by the beginning of the third millenium
More informationObjectives 4/20/2018. Complex Illness Support Alongside Standard Oncology Care for Patients with Incurable Cancer. Outpatient Consultation Service
Function 4/20/2018 Complex Illness Support Alongside Standard Oncology Care for Patients with Incurable Cancer Kim Bland, DNP, APRN-NP, FNP, AOCN Objectives Discuss Complex Illness Support Review rationale
More informationPHARMO Database Network
Pros & cons in Oncology studies PHARMO Myrthe Database van Herk-Sukel, Network PhD 1 Disclosure Myrthe van Herk-Sukel is an employee of the PHARMO Institute for Drug Outcomes Research. This independent
More informationMarital Status, Education, and Income in Relation to the Risk of Esophageal and Gastric Cancer by Histological Type and Site
Marital Status, Education, and in Relation to the Risk of and Gastric Cancer by Histological Type and Site Jesper Lagergren, MD, PhD 1,2 ; Gunnar Andersson, PhD 3 ; Mats Talb ack, PhD 4 ; Sven Drefahl,
More informationVTE Risk Assessment. Challenges of Hemostasis in Cancer Patients. Cihan Ay, MD Associate Professor
Challenges of Hemostasis in Cancer Patients VTE Risk Assessment Cihan Ay, MD Associate Professor Clinical Division of Haematology and Haemostaseology Department of Medicine I, Comprehensive Cancer Center
More informationWeimin YE Professor Department of Medical Epidemiology and Biostatistics Karolinska Institutet
Swedish Health Registers Weimin YE Professor Department of Medical Epidemiology and Biostatistics Karolinska Institutet Overview of Health Registers Nationwide registers National Healthcare Quality Registers
More informationRESEARCH ARTICLE. Comparison between Overall, Cause-specific, and Relative Survival Rates Based on Data from a Population-based Cancer Registry
DOI:http://dx.doi.org/.734/APJCP.22.3..568 RESEARCH ARTICLE Comparison between Overall, Cause-specific, and Relative Survival Rates Based on Data from a Population-based Cancer Registry Mai Utada *, Yuko
More informationSurvival Inequalities among Children, Adolescents and Young Adults with Acute Leukemia in California Renata Abrahão, MD MSc PhD
Survival Inequalities among Children, Adolescents and Young Adults with Acute Leukemia in California Renata Abrahão, MD MSc PhD California Cancer Registrars Association Sacramento November 3 rd, 2016 Objectives
More information2012 Report on Cancer Statistics in Alberta
2012 Report on Cancer Statistics in Alberta Summary Surveillance & Reporting CancerControl AB February 2015 Acknowledgements This report was made possible through Surveillance & Reporting, Cancer Measurement
More informationAnalyses on Cancer Incidence and Mortality in Huai an Area, China, 2010
Open Journal of Preventive Medicine, 2014, 4, 504-512 Published Online June 2014 in SciRes. http://www.scirp.org/journal/ojpm http://dx.doi.org/10.4236/ojpm.2014.46059 Analyses on Cancer Incidence and
More informationInjuries before and after diagnosis of cancer: nationwide register based study
open access Injuries before and after diagnosis of cancer: nationwide register based study Qing Shen, Donghao Lu, Maria E C Schelin, 2, Anna Jöud, 2,4 Yang Cao,,6 Hans-Olov Adami,,7,8 Sven Cnattingius,
More informationCancer Trends in Northern Ireland: D. Fitzpatrick, A. Gavin, D. Donnelly
Cancer Trends in Northern Ireland: 1993-2003 D. Fitzpatrick, A. Gavin, D. Donnelly July 2006 Introduction This report describes trends in cancer cases and deaths for Northern Ireland for the eleven year
More informationMethodology for the Survival Estimates
Methodology for the Survival Estimates Inclusion/Exclusion Criteria Cancer cases are classified according to the International Classification of Diseases for Oncology - Third Edition (ICDO-3) Disease sites
More informationData Resource Profile: The Nordic Obesity Surgery Cohort (NordOSCo)
International Journal of Epidemiology, 2017, 1367 1367g doi: 10.1093/ije/dyx199 Advance Access Publication Date: 10 October 2017 Data Resource Profile Data Resource Profile Data Resource Profile: The Nordic
More informationSocioeconomic characteristics and comorbidities of diverticular disease in Sweden
Int J Colorectal Dis (2017) 32:1591 1596 DOI 10.1007/s00384-017-2853-1 ORIGINAL ARTICLE Socioeconomic characteristics and comorbidities of diverticular disease in Sweden 1997 2012 Maziar Nikberg 1,2 Abbas
More informationPRELIMINARY PROGRAM MAY 31 - JUNE 4, 2019
MONDAY, JUNE 3, 2019 7:30 AM - 9:15 AM HIGHLIGHTS OF THE DAY 8:00 AM - 9:00 AM S 8:00 AM - 9:15 AM S S 8:00 AM - 11:00 AM S Highlights of the Day Session II Bringing New and Innovative Glioblastoma Treatments
More informationCHILDHOOD CANCER SURVIVOR STUDY ANALYSIS CONCEPT PROPOSAL
CHILDHOOD CANCER SURVIVOR STUDY ANALYSIS CONCEPT PROPOSAL 1. Study title: Subsequent neoplasms among survivors of childhood cancer not previously treated with radiation 2. Working group and investigators:
More informationUNC Cancer Epidemiology Seminar: Cancer Risk in New Users of Overactive Bladder Drugs
February 19, 2016 UNC Cancer Epidemiology Seminar: Cancer Risk in New Users of Overactive Bladder Drugs James A. Kaye, MD, DrPH Senior Director, Epidemiology, RTI Health Solutions Collaborators: Andrea
More informationFinancial Disclosure. Learning Objectives. Evaluation of Chemotherapy in Last 2 Weeks of Life: CAMC Patterns of Care
Evaluation of Chemotherapy in Last 2 Weeks of Life: CAMC Patterns of Care Steven J. Jubelirer, MD Clinical Professor Medicine WVU Charleston Division Senior Research Scientist CAMC Research Institute Charleston
More informationNovel Diagnostics and Biomarker Opportunities
1 Novel Diagnostics and Biomarker Opportunities LYMPHOMA EYE HEART BREAST COLON BLADDER CERVIX PROSTATE From research to business Inven2 transforms science and technology into useful and profitable products
More informationPsychological distress in relation to site specific cancer mortality: pooling of unpublished data from 16 prospective cohort studies
open access Psychological distress in relation to site specific cancer mortality: pooling of unpublished data from 16 prospective cohort studies G David Batty, 1 Tom C Russ, 2,3 Emmanuel Stamatakis, 4
More informationAppendix 1 (as supplied by the authors): Supplementary data
Appendix 1 (as supplied by the authors): Supplementary data I. Cancer prevalence in Canada We obtained 10 year person based cancer prevalence rates for all of Canada for some years of our study period
More informationNo clear effect of postoperative radiotherapy on survival of breast cancer patients with one to three positive nodes: a population-based study
Annals of Oncology original articles Annals of Oncology 26: 1149 1154, 2015 doi:10.1093/annonc/mdv159 Published online 3 April 2015 No clear effect of postoperative radiotherapy on survival of breast cancer
More informationAndrogen deprivation therapy for treatment of localized prostate cancer and risk of
Androgen deprivation therapy for treatment of localized prostate cancer and risk of second primary malignancies Lauren P. Wallner, Renyi Wang, Steven J. Jacobsen, Reina Haque Department of Research and
More informationSupplementary Online Content
Supplementary Online Content Toyoda N, Chikwe J, Itagaki S, Gelijns AC, Adams DH, Egorova N. Trends in infective endocarditis in California and New York State, 1998-2013. JAMA. doi:10.1001/jama.2017.4287
More informationA Methodological Issue in the Analysis of Second-Primary Cancer Incidence in Long-Term Survivors of Childhood Cancers
American Journal of Epidemiology Copyright 2003 by the Johns Hopkins Bloomberg School of Public Health All rights reserved Vol. 158, No. 11 Printed in U.S.A. DOI: 10.1093/aje/kwg278 PRACTICE OF EPIDEMIOLOGY
More informationThe updated incidences and mortalities of major cancers in China, 2011
DOI 10.1186/s40880-015-0042-6 REVIEW Open Access The updated incidences and mortalities of major cancers in China, 2011 Wanqing Chen *, Rongshou Zheng, Hongmei Zeng and Siwei Zhang Abstract Introduction:
More informationESPEN Congress Florence 2008
ESPEN Congress Florence 2008 Severe obesity - Session organised in conjunction with ASPEN Long term mortality in cohorts of severely obese subjects D. Mirabelli (Italy) Long-term mortality in cohorts of
More informationTemporal Trends in Demographics and Overall Survival of Non Small-Cell Lung Cancer Patients at Moffitt Cancer Center From 1986 to 2008
Special Report Temporal Trends in Demographics and Overall Survival of Non Small-Cell Lung Cancer Patients at Moffitt Cancer Center From 1986 to 2008 Matthew B. Schabath, PhD, Zachary J. Thompson, PhD,
More informationSCENIHR Public Hearing Luxemburg Roland Laurent Swedish Tanning Association
SCENIHR Public Hearing Luxemburg Swedish Tanning Association Member of TC 412 of EN16489 working group Type-3 Scandinavian countries are type-3 regulated Described in EN 60335-2-27 for home use by unskilled
More informationSurgical resection improves survival in pancreatic cancer patients without vascular invasion- a population based study
Original article Annals of Gastroenterology (2013) 26, 346-352 Surgical resection improves survival in pancreatic cancer patients without vascular invasion- a population based study Subhankar Chakraborty
More informationCitation for the published paper: Epidemiology May;24(3): Abdominal fat and male excess of esophageal adenocarcinoma
This is an author produced version of a paper published in Epidemiology. This paper has been peer-reviewed but does not include the final publisher proof-corrections or journal pagination. Citation for
More informationClinical Study on Prognostic Factors and Nursing of Breast Cancer with Brain Metastases
Clinical Study on Prognostic Factors and Nursing of Breast Cancer with Brain Metastases Ying Zhou 1#, Kefang Zhong 1#, Fang Zhou* 2 ABSTRACT This paper aims to explore the clinical features and prognostic
More informationSummary Report Report on Cancer Statistics in Alberta. February Surveillance and Health Status Assessment Cancer Surveillance
Summary Report 2008 Report on Cancer Statistics in Alberta February 2011 November 25, 2011 ERRATUM: Summary Report, 2008 Report on Cancer Statistics in Alberta There was an error in the spelling of prostate
More informationIncidence and Risk of Alcohol Use Disorders by Age, Gender and Poverty Status: A Population-Based-10 Year Follow-Up Study
Incidence and Risk of Alcohol Use Disorders by Age, Gender and Poverty Status: A Population-Based-10 Year Chun-Te Lee 1,2, Chiu-Yueh Hsiao 3, Yi-Chyan Chen 4,5, Oswald Ndi Nfor 6, Jing-Yang Huang 6, Lee
More informationImmediate Risk for Cardiovascular Events and Suicide Following a Prostate Cancer Diagnosis: Prospective Cohort Study
Immediate Risk for Cardiovascular Events and Suicide Following a Prostate Cancer Diagnosis: Prospective Cohort Study The Harvard community has made this article openly available. Please share how this
More informationMEASURE SPECIFICATIONS
QOPI REPTING REGISTRY (QCDR) 2018 QOPI 5 QOPI 11 Chemotherapy administered to patients with metastatic solid tumor with performance status of 3, 4, or undocumented (Lower Score - Better) Combination chemotherapy
More informationSwedish Initiative for Research on Microdata in the Social And Medical Sciences. What is SIMSAM? Anna Holmström
Swedish Initiative for Research on Microdata in the Social And Medical Sciences What is SIMSAM? Anna Holmström Ph.D., SIMSAM Network Coordinator Dept. of Clinical Neuroscience Insurance Medicine Karolinska
More informationPrediction of Cancer Incidence and Mortality in Korea, 2018
pissn 1598-2998, eissn 256 Cancer Res Treat. 218;5(2):317-323 Special Article https://doi.org/1.4143/crt.218.142 Open Access Prediction of Cancer Incidence and Mortality in Korea, 218 Kyu-Won Jung, MS
More informationMEASURE SPECIFICATIONS
QOPI REPTING REGISTRY (QCDR) 2018 QOPI5 Title Chemotherapy administered to patients with metastatic solid tumor with performance status of 3, 4, or undocumented (Lower Score - Better) Description Percentage
More informationPodocalyxin-like protein as a prognostic marker in colorectal cancer: Functional studies and clinical implication
Podocalyxin-like protein as a prognostic marker in colorectal cancer: Functional studies and clinical implication Karin Jirström Professor, Pathology Lund University, Regional Laboratories Region Skåne
More informationI ing therapy, the most commonly used index
WHEN MAY ENDOMETRIAL CANCER BE CONSIDERED CURED? RICHARD R. MONSON, MD,* BRIAN MACMAHON, &ID,* AND JAMES H. AUSTIN, MD+ To assess when a woman may be considered cured following treatment for endometrial
More informationHow to measure mental health in the general population? Reiner Rugulies
How to measure mental health in the general population? Reiner Rugulies National Research Centre for the Working Environment, Denmark Department of Public Health and Department of Psychology, University
More informationWhat makes us ill?
www.unifr.ch/psycho/en/research/psycli What makes us ill? What makes us ill? Looking for vulnerability factors for mental illness Prof. Dr. Chantal Martin-Soelch In the framework of the burden of mental
More information3. BACKGROUND AND RATIONALE
CHILDHOOD CANCER SURVIVOR STUDY Revised Analysis Concept Proposal 10-17 October 12, 2011 1. STUDY TITLE: Growth Hormone Exposure as a risk factor for the development of Subsequent Central Nervous System
More informationPrediction of Cancer Incidence and Mortality in Korea, 2013
pissn 1598-2998, eissn 256 Cancer Res Treat. 213;45(1):15-21 Special Article http://dx.doi.org/1.4143/crt.213.45.1.15 Open Access Prediction of Cancer Incidence and Mortality in Korea, 213 Kyu-Won Jung,
More informationLANDMARK MEDICAL CENTER CANCER PROGRAM YEAR IN REVIEW 2013
LANDMARK MEDICAL CENTER CANCER PROGRAM YEAR IN REVIEW 2013 Landmark Medical Center offers a comprehensive cancer care services to our patients. LMC Cancer program is committed to ensure that patients receive
More informationThe Current Landscape of Nurse Navigators: Oncology and the Impact on Outcomes
The Current Landscape of Nurse Navigators: Oncology and the Impact on Outcomes SHERYL RILEY RN, OCN, CMCN DIRECTOR OF CLINICAL SERVICES SAI SYSTEMS SRILEY@SAISYSTEMS.COM 2015 SAI SYSTEMS INTERNATIONAL
More information